风险因素,管理,并避免传导系统疾病后,透气管大动脉替换透气管大动脉替换
Mohamad S Alabdaljabar1, Mackram F Eleid2
1Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Journal of clinical medicine
|July 14, 2023
概括
过导管大动脉置换 (TAVR) 可能导致导电疾病,这是一个常见的并发症. 了解患者和程序风险因素是预防和有效管理这种疾病的关键.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械技术 医疗器械技术
背景情况:
- 过导管大动脉置换 (TAVR) 是大动脉狭窄症 (AS) 的关键治疗方法.
- 导电疾病是TAVR后的一个常见而严重的并发症.
- 识别风险因素对于管理TAVR后传导疾病至关重要.
研究的目的:
- 审查TAVR相关传导疾病的发病率和风险因素.
- 讨论TAVR后传导疾病的当前管理策略.
- 突出需要更好的风险分层和预防.
主要方法:
- 对TAVR和导电疾病研究的文献综述.
- 分析患者相关的风险因素 (AS严重程度,化,先前存在的疾病).
- 评估与程序相关的风险因素 (门类型,植入深度,比率,技术).
主要成果:
- 导电疾病的发病率和风险因素是多因素的.
- 患者因素包括AS严重程度,膜化和之前的导电问题.
- 程序因素包括门选择,植入深度和技术.
结论:
- 在TAVR后传导性疾病的风险分层需要全面评估.
- 目前的管理方法各不相同,通常是基于专家意见.
- 需要进一步的研究来规范预防和治疗方案.
相关概念视频
Aortic Regurgitation III: Medical Management
26
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
26
Mitral Stenosis III: Medical Management
13
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13
Mitral Valve Prolapse II: Assessment and Management
23
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
23
Aortic Regurgitation I: Introduction
18
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
18
Mitral Stenosis IV: Nursing Management
15
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
15
Rheumatic Heart Disease III: Medical Management
22
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22


